NO941683L - - Google Patents

Info

Publication number
NO941683L
NO941683L NO941683A NO941683A NO941683L NO 941683 L NO941683 L NO 941683L NO 941683 A NO941683 A NO 941683A NO 941683 A NO941683 A NO 941683A NO 941683 L NO941683 L NO 941683L
Authority
NO
Norway
Prior art keywords
alpha
azacholesta
seco
trien
alkenylene
Prior art date
Application number
NO941683A
Other languages
English (en)
Norwegian (no)
Other versions
NO305315B1 (no
NO941683D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919123712A external-priority patent/GB9123712D0/en
Priority claimed from GB929209658A external-priority patent/GB9209658D0/en
Application filed filed Critical
Publication of NO941683D0 publication Critical patent/NO941683D0/no
Publication of NO941683L publication Critical patent/NO941683L/no
Publication of NO305315B1 publication Critical patent/NO305315B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO941683A 1991-11-07 1994-05-06 Vitamin D-amid-derivater NO305315B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919123712A GB9123712D0 (en) 1991-11-07 1991-11-07 Chemical compounds
GB929209658A GB9209658D0 (en) 1992-05-05 1992-05-05 Chemical compounds
PCT/EP1992/002577 WO1993009093A1 (en) 1991-11-07 1992-11-06 Vitamin d amide derivatives

Publications (3)

Publication Number Publication Date
NO941683D0 NO941683D0 (no) 1994-05-06
NO941683L true NO941683L (de) 1994-06-27
NO305315B1 NO305315B1 (no) 1999-05-10

Family

ID=26299825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941683A NO305315B1 (no) 1991-11-07 1994-05-06 Vitamin D-amid-derivater

Country Status (20)

Country Link
US (2) US5494905A (de)
EP (1) EP0614455B1 (de)
JP (1) JP3282811B2 (de)
KR (1) KR100271461B1 (de)
AT (1) ATE134366T1 (de)
AU (1) AU664213B2 (de)
CA (1) CA2121678C (de)
CZ (1) CZ288031B6 (de)
DE (1) DE69208478T2 (de)
DK (1) DK0614455T3 (de)
ES (1) ES2083771T3 (de)
FI (1) FI106119B (de)
GR (1) GR3019601T3 (de)
HU (1) HU221008B1 (de)
NO (1) NO305315B1 (de)
NZ (1) NZ245041A (de)
PL (1) PL171580B1 (de)
RU (1) RU2139276C1 (de)
SK (1) SK281302B6 (de)
WO (1) WO1993009093A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
WO2004076688A1 (ja) * 1993-02-12 2004-09-10 Etsuro Ogata 無症候腎障害のモニタリング法
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9325415D0 (en) * 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
GB9405715D0 (en) * 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US5678570A (en) * 1995-04-14 1997-10-21 The University Of North Carolina At Chapel Hill Method of treating cardiac arrest
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
DE19619036A1 (de) * 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
GB9804861D0 (en) * 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
EP1123921A4 (de) * 1998-10-23 2003-08-20 Teijin Ltd Vitamin d 3 derivate und diese enthaltende heilmittel für entzündliche erkrankungen der atemwege
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
EP1295871B1 (de) * 2000-06-15 2011-05-18 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivate mit einem 22-oxa- oder 22-thia- atom, einer sauer-, ester- oder amid- substitutierten c17-seitenkette und einer 16(17)-doppelbindung
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
EP2018366A4 (de) * 2006-05-16 2010-08-04 Univ Mcgill Hybridmoleküle mit gemischten vitamin-d-rezeptor-agonismus und histondeacetylase hemmenden eigenschaften
WO2009117831A1 (en) * 2008-03-27 2009-10-01 The Royal Institution For The Advancement Of Learning/Mcgill University Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
JP7475469B2 (ja) * 2020-09-15 2024-04-26 帝人ファーマ株式会社 側鎖に環状アミンを有するビタミンｄ誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217288A (en) * 1977-03-24 1980-08-12 Wisconsin Alumni Research Foundation Anti-vitamin D compounds
FR2426044A2 (fr) * 1978-05-19 1979-12-14 Wisconsin Research Foundation Derives de la vitamine d3 ayant une activite anti-vitamine d
ATE74269T1 (de) * 1987-07-29 1992-04-15 Takeda Chemical Industries Ltd Zellproliferationsinhibitor.
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények

Also Published As

Publication number Publication date
CZ111294A3 (en) 1995-03-15
EP0614455B1 (de) 1996-02-21
DE69208478D1 (de) 1996-03-28
EP0614455A1 (de) 1994-09-14
KR100271461B1 (ko) 2000-11-15
JP3282811B2 (ja) 2002-05-20
FI106119B (fi) 2000-11-30
SK281302B6 (sk) 2001-02-12
HU9401372D0 (en) 1994-08-29
DE69208478T2 (de) 1996-09-05
CA2121678A1 (en) 1993-05-13
RU2139276C1 (ru) 1999-10-10
HU221008B1 (hu) 2002-07-29
ES2083771T3 (es) 1996-04-16
SK52294A3 (en) 1994-11-09
DK0614455T3 (da) 1996-03-18
WO1993009093A1 (en) 1993-05-13
PL171580B1 (pl) 1997-05-30
CZ288031B6 (cs) 2001-04-11
CA2121678C (en) 2005-03-15
GR3019601T3 (en) 1996-07-31
FI942114L (fi) 1994-05-06
NO305315B1 (no) 1999-05-10
FI942114A0 (fi) 1994-05-06
HUT67140A (en) 1995-02-28
US5686435A (en) 1997-11-11
NZ245041A (en) 1995-03-28
NO941683D0 (no) 1994-05-06
JPH07502499A (ja) 1995-03-16
AU2901492A (en) 1993-06-07
AU664213B2 (en) 1995-11-09
US5494905A (en) 1996-02-27
ATE134366T1 (de) 1996-03-15

Similar Documents

Publication Publication Date Title
NO941683L (de)
IL104489A0 (en) Carbamates and crop protection agents containing them
HU9503190D0 (en) Vitamin d amide derivatives
ATE48010T1 (de) Schlagzaeh modifiziertes polyoxymethylen und daraus hergestellte formkoerper.
ES2126636T3 (es) Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria.
GB8707120D0 (en) Antiarrhythmic agents
EP0379483A4 (en) 1,2,3,4,10,14b-hexahydrodibenzo c,f¨pyrazino- 1,2-a¨azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
ES8705853A1 (es) Un procedimiento para la produccion de derivados de benzoilurea
EP0532629A4 (de)
EP0269041A3 (en) Fungicidal cyclohexylamines
YU186689A (en) N-sulphenilated and n-acylated pyrazolins
ES8504828A1 (es) Procedimiento para la obtencion de un derivado de organofosfato.
AP9300580A0 (en) Oxa- and thiadiazole derivatives.
JPS5795956A (en) Hydroxamic acid esters, manufacture, use as insecticide and intermediate therefor
ES8506297A1 (es) Procedimiento para la obtencion de 1, 3, 5-tiadiazin-2-tioxo-4-onas 3, 6-disustituidas
ES8300704A1 (es) Un procedimiento para la preparacion del n-oxido del 4 hetoxi-n-(2-(-(imetil-2-piperidil) etil) fenil)benzamida.
DE69200523D1 (de) Polyglukosiden aus Hydroxyalkylsorbit.
ATE41849T1 (de) Herbizide.